Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Biologic correlates of beneficial convalescent plasma therapy in a COVID-19 patient reveal disease resolution mechanisms

View ORCID ProfileNatalie Bruiners, Valentina Guerrini, View ORCID ProfileRahul Ukey, Ryan Dikdan, Jason Yang, Pankaj Kumar Mishra, Alberta Onyuka, Deborah Handler, Joshua Vieth, Mary Carayannopulos, Shuang Guo, Maressa Pollen, Abraham Pinter, Sanjay Tyagi, Daniel Feingold, Claire Philipp, Steven Libutti, Maria Laura Gennaro
doi: https://doi.org/10.1101/2022.02.03.22269612
Natalie Bruiners
1Public Health Research Institute, Rutgers New Jersey Medical School, Newark, NJ 07103
3Department of Medicine, Rutgers New Jersey Medical School, Newark, NJ 07103
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Natalie Bruiners
Valentina Guerrini
1Public Health Research Institute, Rutgers New Jersey Medical School, Newark, NJ 07103
3Department of Medicine, Rutgers New Jersey Medical School, Newark, NJ 07103
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rahul Ukey
1Public Health Research Institute, Rutgers New Jersey Medical School, Newark, NJ 07103
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Rahul Ukey
Ryan Dikdan
1Public Health Research Institute, Rutgers New Jersey Medical School, Newark, NJ 07103
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jason Yang
4Department of Microbiology, Biochemistry and Molecular Genetics, Rutgers New Jersey Medical School, Newark, NJ 07103
5Center for Emerging and Re-emerging Pathogens, Rutgers New Jersey Medical School, Newark, NJ 07103
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pankaj Kumar Mishra
1Public Health Research Institute, Rutgers New Jersey Medical School, Newark, NJ 07103
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alberta Onyuka
2Global Tuberculosis Institute, Rutgers New Jersey Medical School, Newark, NJ 07103
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Deborah Handler
2Global Tuberculosis Institute, Rutgers New Jersey Medical School, Newark, NJ 07103
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Joshua Vieth
6Cancer Institute of New Jersey, Rutgers University, New Brunswick, NJ 08903
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mary Carayannopulos
7Department of Pathology and Laboratory Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ 08901
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shuang Guo
8Division of Hematology, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ 08901
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Maressa Pollen
7Department of Pathology and Laboratory Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ 08901
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Abraham Pinter
1Public Health Research Institute, Rutgers New Jersey Medical School, Newark, NJ 07103
3Department of Medicine, Rutgers New Jersey Medical School, Newark, NJ 07103
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sanjay Tyagi
1Public Health Research Institute, Rutgers New Jersey Medical School, Newark, NJ 07103
3Department of Medicine, Rutgers New Jersey Medical School, Newark, NJ 07103
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Daniel Feingold
9Department of Surgery, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ 08901
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Claire Philipp
8Division of Hematology, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ 08901
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Steven Libutti
6Cancer Institute of New Jersey, Rutgers University, New Brunswick, NJ 08903
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: steven.libutti{at}cinj.rutgers.edu marila.gennaro{at}rutgers.edu
Maria Laura Gennaro
1Public Health Research Institute, Rutgers New Jersey Medical School, Newark, NJ 07103
3Department of Medicine, Rutgers New Jersey Medical School, Newark, NJ 07103
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: steven.libutti{at}cinj.rutgers.edu marila.gennaro{at}rutgers.edu
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Background While the biomarkers of COVID-19 severity have been thoroughly investigated, the key biological dynamics associated with COVID-19 resolution are still insufficiently understood.

Main body We report a case of full resolution of severe COVID-19 due to convalescent plasma transfusion in a patient with underlying multiple autoimmune syndrome. Following transfusion, the patient showed fever remission, improved respiratory status, and rapidly decreased viral burden in respiratory fluids and SARS-CoV-2 RNAemia. Longitudinal unbiased proteomic analysis of plasma and single-cell transcriptomics of peripheral blood cells conducted prior to and at multiple times after convalescent plasma transfusion identified the key biological processes associated with the transition from severe disease to disease-free state. These included (i) temporally ordered upward and downward changes in plasma proteins reestablishing homeostasis and (ii) post-transfusion disappearance of a particular subset of dysfunctional monocytes characterized by hyperactivated Interferon responses and decreased TNF-α signaling.

Conclusions Monitoring specific subsets of innate immune cells in peripheral blood may provide prognostic keys in severe COVID-19. Moreover, understanding disease resolution at the molecular and cellular level should contribute to identify targets of therapeutic interventions against severe COVID-19.

Competing Interest Statement

Rutgers University has filed for patent protection for various aspects of anti-SARS-CoV-2 antibody detection and its uses. M.L.G. is a consultant for Biomerieux.

Funding Statement

This work was funded by NIH grants R01 HL149450, R01 HL149450-S1, R61 HD105619, R01 AI158911, U01 AI122285-S1, UL1 TR003017, and R00 GM118907. Work performed at the Rutgers Biological Mass Spectrometry Facility was partially supported by NIH S10 OD025140.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

All study activities were approved by the Rutgers Institutional Review Board (Pro2020000655).

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

All data produced in the present study are available upon reasonable request to the authors

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Back to top
PreviousNext
Posted February 03, 2022.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Biologic correlates of beneficial convalescent plasma therapy in a COVID-19 patient reveal disease resolution mechanisms
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Biologic correlates of beneficial convalescent plasma therapy in a COVID-19 patient reveal disease resolution mechanisms
Natalie Bruiners, Valentina Guerrini, Rahul Ukey, Ryan Dikdan, Jason Yang, Pankaj Kumar Mishra, Alberta Onyuka, Deborah Handler, Joshua Vieth, Mary Carayannopulos, Shuang Guo, Maressa Pollen, Abraham Pinter, Sanjay Tyagi, Daniel Feingold, Claire Philipp, Steven Libutti, Maria Laura Gennaro
medRxiv 2022.02.03.22269612; doi: https://doi.org/10.1101/2022.02.03.22269612
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Biologic correlates of beneficial convalescent plasma therapy in a COVID-19 patient reveal disease resolution mechanisms
Natalie Bruiners, Valentina Guerrini, Rahul Ukey, Ryan Dikdan, Jason Yang, Pankaj Kumar Mishra, Alberta Onyuka, Deborah Handler, Joshua Vieth, Mary Carayannopulos, Shuang Guo, Maressa Pollen, Abraham Pinter, Sanjay Tyagi, Daniel Feingold, Claire Philipp, Steven Libutti, Maria Laura Gennaro
medRxiv 2022.02.03.22269612; doi: https://doi.org/10.1101/2022.02.03.22269612

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (427)
  • Allergy and Immunology (753)
  • Anesthesia (220)
  • Cardiovascular Medicine (3281)
  • Dentistry and Oral Medicine (362)
  • Dermatology (274)
  • Emergency Medicine (478)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (1164)
  • Epidemiology (13337)
  • Forensic Medicine (19)
  • Gastroenterology (896)
  • Genetic and Genomic Medicine (5128)
  • Geriatric Medicine (479)
  • Health Economics (781)
  • Health Informatics (3251)
  • Health Policy (1137)
  • Health Systems and Quality Improvement (1189)
  • Hematology (427)
  • HIV/AIDS (1012)
  • Infectious Diseases (except HIV/AIDS) (14611)
  • Intensive Care and Critical Care Medicine (908)
  • Medical Education (475)
  • Medical Ethics (126)
  • Nephrology (521)
  • Neurology (4898)
  • Nursing (261)
  • Nutrition (725)
  • Obstetrics and Gynecology (879)
  • Occupational and Environmental Health (795)
  • Oncology (2515)
  • Ophthalmology (722)
  • Orthopedics (280)
  • Otolaryngology (346)
  • Pain Medicine (323)
  • Palliative Medicine (90)
  • Pathology (537)
  • Pediatrics (1297)
  • Pharmacology and Therapeutics (548)
  • Primary Care Research (554)
  • Psychiatry and Clinical Psychology (4189)
  • Public and Global Health (7482)
  • Radiology and Imaging (1700)
  • Rehabilitation Medicine and Physical Therapy (1010)
  • Respiratory Medicine (979)
  • Rheumatology (478)
  • Sexual and Reproductive Health (495)
  • Sports Medicine (424)
  • Surgery (545)
  • Toxicology (71)
  • Transplantation (235)
  • Urology (203)